EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Perioperative Thyroid-Metabolic Changes in Pancreatic Ductal Adenocarcinoma According to Surgical Management

Oliwia Grząsiak-Kraj iD, Tomasz Kraj iD, Alicja Majos, Aleksander Wardęszkiewicz, Aneta Szmiel, Krzysztof Poznański, Adam Durczyński, Piotr Hogendorf, Janusz Strzelczyk

Cancers · 28.05.2026 · 18 (11) · 1769

DOI: 10.3390/cancers18111769 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancers, online erschienen am 28.05.2026. Verfasst von Oliwia Grząsiak-Kraj und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of General and Transplant Surgery, Medical University of Lodz, 90-419 Lodz, Poland. Die Arbeit nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Pancreatic ductal adenocarcinoma (PDAC) is associated not only with tumor progression but also with profound metabolic and nutritional disturbances. Thyroid hormone homeostasis may reflect this systemic response; however, perioperative data in PDAC remain limited. We aimed to assess perioperative changes in thyroid-related parameters in patients with PDAC undergoing different types of surgical management and to explore their associations with nutritional, metabolic, and tumor-burden variables.

Methods

We performed a retrospective single-center study including 101 patients with PDAC. Thyroid-related and metabolic laboratory parameters were assessed before surgery and again 4–6 weeks later. The analyzed variables included thyroid-stimulating hormone (TSH), free triiodothyronine (FT3), free thyroxine (FT4), the FT3/FT4 ratio, albumin, total protein, glucose, insulin, HbA1c, lipid parameters, and CA 19-9. Patients were analyzed according to resectional versus non-resectional treatment and according to four procedure types. The primary endpoint was perioperative change in the FT3/FT4 ratio.

Results

At baseline, resectional patients had significantly higher FT3 and FT3/FT4 ratio values and lower FT4 and CA 19-9 levels than non-resectional patients. In the whole cohort, FT3 and the FT3/FT4 ratio decreased significantly after treatment, whereas TSH increased, and FT4 remained unchanged. These endocrine changes occurred in parallel with significant declines in albumin, total protein, glucose, insulin, HbA1c, and HDL cholesterol, together with an increase in triglyceride levels. Baseline FT3 and FT3/FT4 ratios correlated positively with albumin and total protein and negatively with CA 19-9. Although perioperative changes did not differ significantly between resectional and non-resectional groups except for triglycerides, significant procedure-dependent differences were observed across the four surgical categories for FT3, FT4, TSH, and the FT3/FT4 ratio; glucose; insulin; and triglycerides. The prevalence of low-T3 syndrome increased from 11.1% preoperatively to 38.7% postoperatively.

Conclusions

In PDAC, perioperative changes in thyroid hormone indices are pronounced and strongly depend on the type of surgical management. FT3 and the FT3/FT4 ratio appear to reflect systemic metabolic and nutritional adaptation as well as disease burden rather than acting as tumor-specific markers.

Schlagwörter

Stichwörter der Autor:innen

FT3/FT4 ratiolow-T3 syndromemetabolic responsenutritional statuspancreatic ductal adenocarcinomapancreatic surgeryperioperative changesthyroid hormones

Autor:innen und Institutionen

  • Department of General and Transplant Surgery, Medical University of Lodz, 90-419 Lodz, Poland.
  • Department of Vascular Surgery and Angiology, Independent Public Healthcare Institution of the Ministry of the Interior and Administration in Lodz, 91-425 Lodz, Poland.
  • Institute of Medical Expertise in Lodz, 91-205 Lodz, Poland.

ORCID-Profile: Oliwia Grząsiak-Kraj, Tomasz Kraj

Zitieren

APA

Grząsiak-Kraj, O., Kraj, T., Majos, A., Wardęszkiewicz, A., Szmiel, A., Poznański, K., Durczyński, A., Hogendorf, P., & Strzelczyk, J. (2026). Perioperative Thyroid-Metabolic Changes in Pancreatic Ductal Adenocarcinoma According to Surgical Management. Cancers, 18(11), 1769. https://doi.org/10.3390/cancers18111769

Vancouver

Grząsiak-Kraj O, Kraj T, Majos A, Wardęszkiewicz A, Szmiel A, Poznański K, et al. Perioperative Thyroid-Metabolic Changes in Pancreatic Ductal Adenocarcinoma According to Surgical Management. Cancers. 2026;18(11):1769. doi:10.3390/cancers18111769

BibTeX
@article{GrzsiakKraj2026,
  author = {Grząsiak-Kraj, Oliwia and Kraj, Tomasz and Majos, Alicja and Wardęszkiewicz, Aleksander and Szmiel, Aneta and Poznański, Krzysztof and Durczyński, Adam and Hogendorf, Piotr and Strzelczyk, Janusz},
  title = {Perioperative Thyroid-Metabolic Changes in Pancreatic Ductal Adenocarcinoma According to Surgical Management},
  journal = {Cancers},
  year = {2026},
  volume = {18},
  number = {11},
  pages = {1769},
  doi = {10.3390/cancers18111769}
}
Kostenlos starten →